HCPLive Network
Latest Oncology Headlines
Thursday, October 23, 2014
By Douglas Moeller, MD
Virtually everyone in the clinical laboratory business is now acquainted with Z-code identifiers. Each unique laboratory test should have a unique tracking code, even if more than one Z-code identifier is reported with a corresponding American Medical Association’s Current Procedural Terminology (CPT) billing code.
Thursday, October 23, 2014
The US health care system ranks last compared to other industrialized nations when it comes to affordability and patient access, according to a new survey published in the Oct. 23 issue of the New England Journal of Medicine.
Thursday, October 23, 2014
For patients with untreated metastatic colorectal cancer, chemotherapy with fluorouracil, leucovorin, oxaliplatin, and irinotecan plus bevacizumab improves outcome versus fluorouracil, leucovorin, and irinotecan plus bevacizumab, according to a study published in the Oct. 23 issue of the New England Journal of Medicine.
Thursday, October 23, 2014
Americans are less trusting of the medical profession than people in many other countries -- even though they often like their own doctor, according to a new report. The findings were published in the Oct. 23 issue of the New England Journal of Medicine.
Thursday, October 23, 2014
Coping strategies are frequently adopted for financial distress associated with cancer care, according to research scheduled to be presented at the American Society of Clinical Oncology's inaugural Palliative Care in Oncology Symposium, held from Oct. 24 to 25 in Boston.
Thursday, October 23, 2014
By Raoul S. Concepcion, MD
Over the past 6 months, we have had two studies that will profoundly affect our management of advanced prostate cancer patients.
Wednesday, October 22, 2014
By Christina Izzo
Janssen Research & Development, LLC, has submitted a supplemental New Drug Application for ibrutinib (Imbruvica) as treatment for patients with Waldenström's macroglobulinemia (WM).
Wednesday, October 22, 2014
Hospital conversion to for-profit status is associated with improvements in financial margins, but has no effect on process quality metrics or mortality rates, according to a study published in the Oct. 22/29 issue of the Journal of the American Medical Association
Wednesday, October 22, 2014
Increasing use of hospice in the final days of ovarian cancer does not offset intensive end-of-life care in older women, according to a study published online Oct. 6 in the Journal of Clinical Oncology.
Wednesday, October 22, 2014
Drug coupons could reduce patients' out-of-pocket costs by 60 percent, according to a study published in the October issue of Health Affairs.
Wednesday, October 22, 2014
Access to an employer-sponsored private price transparency platform is associated with reduced total claims payments, according to research published in the Oct. 22/29 issue of the Journal of the American Medical Association.
Wednesday, October 22, 2014
By Gina Battaglia, PhD
Substantial clinical trial evidence supports the use of pathologic complete response (pCR) as a measure for evaluating neoadjuvant therapies for patients with HER2-positive breast cancer, suggesting that preoperative treatment should be the standard of care
Tuesday, October 21, 2014
By Andrew J. Roth
Ibrutinib has been approved by the European Commission for the treatment of adult patients with relapsed or refractory MCL and adult patients with CLL.
Tuesday, October 21, 2014
By Beth Fand Incollingo
Despite the promise associated with biomarker-based tools as a means of helping to guide cancer diagnosis and treatment, there is a potential stumbling block: insurance reimbursement.
Tuesday, October 21, 2014
A state law that requires plaintiffs to release relevant protected health information before proceeding with allegations of medical liability has been upheld by a federal appeals court, according to the American Medical Association.
Tuesday, October 21, 2014
Unplanned hospitalizations among elderly patients with gastrointestinal cancer are common, according to research published online Oct. 6 in the Journal of Clinical Oncology.
Tuesday, October 21, 2014
By Tony Berberabe, MPH
It seems like big data is everywhere these days. It’s being touted as a solution for physicians and practices who would like to participate in Accountable Care Organizations (ACOs) and accountable care-like contracts with payers.
Monday, October 20, 2014
By Silas Inman
The FDA has granted a fast track designation to TAS-102 (tipiracil hydrochloride) as a treatment for patients with refractory metastatic colorectal cancer (mCRC), according to an announcement by Taiho Oncology, the company developing the drug in the United States.
Monday, October 20, 2014
By Silas Inman
The treatment of patients with chronic lymphocytic leukemia (CLL) has undergone a dramatic transformation in the past year, with the approval of the novel oral agents ibrutinib (Imbruvica) and idelalisib (Zydelig).
Monday, October 20, 2014
By Jacqueline Claudia Barrientos, MD
The treatment landscape for patients with chronic lymphocytic leukemia (CLL) is rapidly changing, with the emergence of four new therapeutic options for this malignancy in recent months.
Physician's Money Digest
Dollar bulls have hit a rocky patch. Buying the US currency has been the favored trade of currency investors since last year's taper tantrum, when the Federal Reserve said it would ease its bond-buying scheme as the economy showed signs of improvement.
Hospital quality data could have a big impact on how patients consume healthcare, but in a report released alongside the search revamp, Healthgrades makes the case that steering patients to only the most competent physicians can have wider implications for the healthcare system.